With the growing appreciation that changes to specific molecules can reflect the broader biochemical anomalies arising from the cancer state, the study of lipids and small-molecule metabolites has become increasingly important for cancer research. The objective of the Virginia Commonwealth University (VCU) Lipidomics/Metabolomics Core (VLMC) is therefore to provide cost effective lipid and small-metabolite analyses for VCU Massey Cancer Center (MCC) members. The VLMC supports the ability of MCC members to qualitatively and highly quantitatively investigate the lipidome and metabolome both in vitro and in vivo studies involving cancer cell lines, preclinical animal models of cancer, and/or patients with cancer. The VLMC does so by providing and maintaining a dedicated advanced lipidomic and metabolomic instrumentation suite that is nationally competitive. Specifically, the VLMC maintains 4 advanced QTRAP-type mass analyzers, each equipped with an ultra-performance liquid chromatography (UPLC) system. An additional quadrupole time-of- flight mass analyzer is equipped with a differential mobility source and a UPLC. In addition to instrumentation, the VLMC has developed, deployed, and proven state-of-the-art methodologies that contemplate overlapping targeted, semi-targeted, and non-targeted approaches to the identification and quantification of changes to the lipidome and metabolome in a high-throughput fashion and over a large dynamic range. The resource is directed by Charles Chalfant, PhD, who is supported by the technical director, D. Shanaka Wijesinghe, PhD, and an additional 2.0 FTEs. The resource director and/or staff support MCC programmatic science by providing consultative services for experimental design and data interpretation, method development, education to certify end-users in the use of the equipment, operator-assisted analysis, and instrument maintenance. The VLMC is a jointly managed (MCC and VCU) resource within close walking distance of MCC. Standard hours for the facility are 9:00 AM until 5:00 PM, Monday through Friday, with certified users enjoying access 24 hours per day, 7 days per week. The usage of services and equipment is tracked and charged back. The VLMC adds significant value to MCC research by providing services that are critical to addressing the research questions of MCC members, services that otherwise would not be practically obtainable or would be cost prohibitive through alternative vendors or even other non-profit institutions. Overall, the instrumentation and expertise available in the VLMC have facilitated the development of a growing user base of MCC members, whose cancer-related research routinely garners peer-reviewed national funding and is published in high-impact scientific journals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016059-38
Application #
9692635
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
38
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Curry, Zachary A; Wilkerson, Jenny L; Bagdas, Deniz et al. (2018) Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 366:169-183
Radwa?ska, Malwina J; Jaskó?owski, Mateusz; Davydova, Elena et al. (2018) The structure of the C-terminal domain of the nucleoprotein from the Bundibugyo strain of the Ebola virus in complex with a pan-specific synthetic Fab. Acta Crystallogr D Struct Biol 74:681-689
Ginder, Gordon D; Williams Jr, David C (2018) Readers of DNA methylation, the MBD family as potential therapeutic targets. Pharmacol Ther 184:98-111
Lancina 3rd, Michael G; Wang, Juan; Williamson, Geoffrey S et al. (2018) DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment. Mol Pharm 15:2883-2889
Vascak, Michal; Jin, Xiaotao; Jacobs, Kimberle M et al. (2018) Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury. Cereb Cortex 28:1625-1644
Chernoukhov, A; Hussein, A; Nkurunziza, S et al. (2018) Bayesian inference in time-varying additive hazards models with applications to disease mapping. Environmetrics 29:
Karandashova, Sophia; Kummarapurugu, Apparao B; Zheng, Shuo et al. (2018) Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase. Am J Physiol Lung Cell Mol Physiol 314:L206-L214
Iqbal, Emil S; Dods, Kara K; Hartman, Matthew C T (2018) Ribosomal incorporation of backbone modified amino acids via an editing-deficient aminoacyl-tRNA synthetase. Org Biomol Chem 16:1073-1078
Meader, Victoria Kathryn; John, Mallory G; Frias Batista, Laysa M et al. (2018) Radical Chemistry in a Femtosecond Laser Plasma: Photochemical Reduction of Ag? in Liquid Ammonia Solution. Molecules 23:
Dai, Lu; Smith, Charles D; Foroozesh, Maryam et al. (2018) The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. Int J Cancer 142:2153-2162

Showing the most recent 10 out of 586 publications